{"id":136668,"date":"2023-08-15T15:09:52","date_gmt":"2023-08-15T19:09:52","guid":{"rendered":"https:\/\/www.ucf.edu\/news\/?p=136668"},"modified":"2023-08-15T15:09:52","modified_gmt":"2023-08-15T19:09:52","slug":"ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis","status":"publish","type":"post","link":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/","title":{"rendered":"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis"},"content":{"rendered":"<p>A <a href=\"https:\/\/www.ucf.edu\/college\/medicine\/\">College of Medicine <\/a>researcher is developing a new antibiotic related to penicillin to treat tuberculosis (TB) and related lung infections.<\/p>\n<p><a href=\"https:\/\/med.ucf.edu\/biomed\/person\/dr-kyle-rohde\/\">Kyle Rohde<\/a>, an infectious disease expert, recently received a $3.4 million, five-year grant from the National Institutes of Health to create new antibiotics that target mycobacterial infections caused by pathogens such as\u00a0<em>Mycobacterium tuberculosis\u00a0<\/em>and\u00a0<em>Mycobacterium abscessus<\/em>.<\/p>\n<p>TB infected 11 million people in 2021, ranking it 13th as the leading cause of death worldwide. While TB numbers started to decline during COVID-19, they are rising again. The infection spreads through airborne droplets released when an infected person coughs or sneezes. Symptoms include coughing up blood, difficulty breathing, fever and chills. If left untreated, TB can be fatal.<\/p>\n<p>\u201cThankfully, only 1 in 10 people who get infected develop symptoms in the short term. But infected people who don\u2019t get sick right away can still develop so-called latent infections and can be carriers for years,\u201d says Rohde. \u201cIf the infection is not detected and treated early on, the bacteria can enter the patient\u2019s bloodstream and spread to various parts of the body such as bones, brain and liver.\u201d<\/p>\n<p>Although rare in the U.S., TB infections are prevalent globally with high numbers found in places like India, China, sub-Saharan Africa, Russia and Brazil and spreads easily in crowded populations.<\/p>\n<p>The current standard treatment for TB involves a combination of drugs taken over four to six months or much longer for drug-resistant strains. Treatments of\u00a0<em>M. abscessus\u00a0<\/em>infections are even longer, less effective, and require IV antibiotics. However, due to the side-effects and duration of these regimens, many patients fail to complete their treatment.<\/p>\n<p>Rohde\u2019s research aims to develop new treatments that shorten treatment times, eradicate drug-resistant strains and minimize side effects.<\/p>\n<p>Penicillin, the prototype of one of the oldest and most used class of antibiotics known as beta-lactams, is not effective against mycobacteria. However, Rohde says, \u201cWe\u2019re starting to understand why the old penicillin didn\u2019t work on TB and why these new types of beta-lactam antibiotics called carbapenems do.<\/p>\n<p>In collaboration with chemist John Buynak of South Methodist University in Texas, Rohde\u2019s team will synthesize and test \u201cnext-gen\u201d carbapenem drugs that they can optimize to target TB.\u00a0\u00a0The optimized antibiotics will be designed to resist enzymes the bacteria use to inactivate the drug while also destroying the bacteria\u2019s cell wall.<\/p>\n<p>Additional members of the team include Leighanne Basta, a U.S. Naval Academy biochemist and expert in the enzymes targeted by these drugs, and Konstantin Korotkov, a structural biologist with the University of Kentucky, who will create the 3D structures of the drugs and ways they can bind to their target.<\/p>\n<p>The team aims to develop a potent antimycobacterial agent that can be administered orally and will test the new drug against TB and related pathogens in mice models.<\/p>\n<p>\u201cAlthough it can take years for new antibiotic candidates to reach patients or even clinical trials, I am optimistic that this project will yield valuable contributions to global efforts to discover new and improved treatment options for these debilitating and hard-to-treat infections,\u201d Rohde says.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Current standard treatments involve a combination of drugs taken over at least four to six months, which many patients fail to complete due to the duration and side-effects of these regimens.<\/p>\n","protected":false},"author":57,"featured_media":136669,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"lazy_load_responsive_images_disabled":false,"footnotes":"","_links_to":"","_links_to_target":"","_wp_rev_ctl_limit":""},"categories":[12],"tags":[979,22543,13434],"tu_author":[],"class_list":["post-136668","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-college-of-medicine","tag-healthcare","tag-kyle-rohde"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis | University of Central Florida News<\/title>\n<meta name=\"description\" content=\"Current standard treatments involve a combination of drugs taken over at least four to six months, which many patients fail to complete due to the duration and side-effects of these regimens.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis\" \/>\n<meta property=\"og:description\" content=\"Current standard treatments involve a combination of drugs taken over at least four to six months, which many patients fail to complete due to the duration and side-effects of these regimens.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/\" \/>\n<meta property=\"og:site_name\" content=\"University of Central Florida News | UCF Today\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UCF\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-15T19:09:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2023\/08\/UCF_Kyle-Rhodes.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicole Dudenhoefer &#039;17\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UCF\" \/>\n<meta name=\"twitter:site\" content=\"@UCF\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicole Dudenhoefer &#039;17\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/\"},\"author\":{\"name\":\"Nicole Dudenhoefer '17\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#\\\/schema\\\/person\\\/9d80c5f96623baaf4ec084540ceb2407\"},\"headline\":\"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis\",\"datePublished\":\"2023-08-15T19:09:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/\"},\"wordCount\":525,\"image\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2023\\\/08\\\/UCF_Kyle-Rhodes.jpg\",\"keywords\":[\"College of Medicine\",\"Healthcare\",\"Kyle Rohde\"],\"articleSection\":[\"Health &amp; Medicine\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2023\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/\",\"url\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/\",\"name\":\"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis | University of Central Florida News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2023\\\/08\\\/UCF_Kyle-Rhodes.jpg\",\"datePublished\":\"2023-08-15T19:09:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#\\\/schema\\\/person\\\/9d80c5f96623baaf4ec084540ceb2407\"},\"description\":\"Current standard treatments involve a combination of drugs taken over at least four to six months, which many patients fail to complete due to the duration and side-effects of these regimens.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2023\\\/08\\\/UCF_Kyle-Rhodes.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2023\\\/08\\\/UCF_Kyle-Rhodes.jpg\",\"width\":1200,\"height\":800,\"caption\":\"Kyle Rohde analyzes data on tuberculosis research at Burnett School of Biomedical Sciences in UCF's College of Medicine.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/\",\"name\":\"University of Central Florida News | UCF Today\",\"description\":\"Central Florida Research, Arts, Technology, Student Life and College News, Stories and More\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#\\\/schema\\\/person\\\/9d80c5f96623baaf4ec084540ceb2407\",\"name\":\"Nicole Dudenhoefer '17\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0eafe9f8522ea36420e16503c4ea5eded2f876d29a0c189ed66c195f65ced6e9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0eafe9f8522ea36420e16503c4ea5eded2f876d29a0c189ed66c195f65ced6e9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0eafe9f8522ea36420e16503c4ea5eded2f876d29a0c189ed66c195f65ced6e9?s=96&d=mm&r=g\",\"caption\":\"Nicole Dudenhoefer '17\"},\"url\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/author\\\/ni563285\\\/\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\\\/#local-main-organization-logo\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"University of Central Florida\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis | University of Central Florida News","description":"Current standard treatments involve a combination of drugs taken over at least four to six months, which many patients fail to complete due to the duration and side-effects of these regimens.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/","og_locale":"en_US","og_type":"article","og_title":"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis","og_description":"Current standard treatments involve a combination of drugs taken over at least four to six months, which many patients fail to complete due to the duration and side-effects of these regimens.","og_url":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/","og_site_name":"University of Central Florida News | UCF Today","article_publisher":"https:\/\/www.facebook.com\/UCF","article_published_time":"2023-08-15T19:09:52+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2023\/08\/UCF_Kyle-Rhodes.jpg","type":"image\/jpeg"}],"author":"Nicole Dudenhoefer '17","twitter_card":"summary_large_image","twitter_creator":"@UCF","twitter_site":"@UCF","twitter_misc":{"Written by":"Nicole Dudenhoefer '17","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#article","isPartOf":{"@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/"},"author":{"name":"Nicole Dudenhoefer '17","@id":"https:\/\/www.ucf.edu\/news\/#\/schema\/person\/9d80c5f96623baaf4ec084540ceb2407"},"headline":"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis","datePublished":"2023-08-15T19:09:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/"},"wordCount":525,"image":{"@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2023\/08\/UCF_Kyle-Rhodes.jpg","keywords":["College of Medicine","Healthcare","Kyle Rohde"],"articleSection":["Health &amp; Medicine"],"inLanguage":"en-US","copyrightYear":"2023","copyrightHolder":{"@id":"https:\/\/www.ucf.edu\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/","url":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/","name":"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis | University of Central Florida News","isPartOf":{"@id":"https:\/\/www.ucf.edu\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#primaryimage"},"image":{"@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2023\/08\/UCF_Kyle-Rhodes.jpg","datePublished":"2023-08-15T19:09:52+00:00","author":{"@id":"https:\/\/www.ucf.edu\/news\/#\/schema\/person\/9d80c5f96623baaf4ec084540ceb2407"},"description":"Current standard treatments involve a combination of drugs taken over at least four to six months, which many patients fail to complete due to the duration and side-effects of these regimens.","breadcrumb":{"@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#primaryimage","url":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2023\/08\/UCF_Kyle-Rhodes.jpg","contentUrl":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2023\/08\/UCF_Kyle-Rhodes.jpg","width":1200,"height":800,"caption":"Kyle Rohde analyzes data on tuberculosis research at Burnett School of Biomedical Sciences in UCF's College of Medicine."},{"@type":"BreadcrumbList","@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ucf.edu\/news\/"},{"@type":"ListItem","position":2,"name":"UCF Scientist Received NIH Grant to Develop New Antibiotic for Tuberculosis"}]},{"@type":"WebSite","@id":"https:\/\/www.ucf.edu\/news\/#website","url":"https:\/\/www.ucf.edu\/news\/","name":"University of Central Florida News | UCF Today","description":"Central Florida Research, Arts, Technology, Student Life and College News, Stories and More","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ucf.edu\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.ucf.edu\/news\/#\/schema\/person\/9d80c5f96623baaf4ec084540ceb2407","name":"Nicole Dudenhoefer '17","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0eafe9f8522ea36420e16503c4ea5eded2f876d29a0c189ed66c195f65ced6e9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0eafe9f8522ea36420e16503c4ea5eded2f876d29a0c189ed66c195f65ced6e9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0eafe9f8522ea36420e16503c4ea5eded2f876d29a0c189ed66c195f65ced6e9?s=96&d=mm&r=g","caption":"Nicole Dudenhoefer '17"},"url":"https:\/\/www.ucf.edu\/news\/author\/ni563285\/"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ucf.edu\/news\/ucf-scientist-received-nih-grant-to-develop-new-antibiotic-for-tuberculosis\/#local-main-organization-logo","url":"","contentUrl":"","caption":"University of Central Florida"}]}},"thumbnail":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2023\/08\/UCF_Kyle-Rhodes-300x200.jpg","primary_category":12,"primary_tag":979,"author_byline":"Suhtling Wong","acf":[],"_links":{"self":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts\/136668","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/comments?post=136668"}],"version-history":[{"count":3,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts\/136668\/revisions"}],"predecessor-version":[{"id":136672,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts\/136668\/revisions\/136672"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/media\/136669"}],"wp:attachment":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/media?parent=136668"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/categories?post=136668"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/tags?post=136668"},{"taxonomy":"tu_author","embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/tu_author?post=136668"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}